Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5879 posts found.

download

Hanmi Pharma shares crash after shock contract termination

September 30, 2016 Manufacturing and Production, Medical Communications, Research and Development Boehringer Ingelheim, Genentech, Germany, HM61713, Hanmi Pharmaceutical, Tagrisso, south korea

News broke on 29 September that Hanmi Pharma, South Korea’s leading drug maker, had signed a $910 million deal with …
News
brian_mcnamara

GSK appoints Brian McNamara chief of consumer health division

September 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brian McNamara, Emma Walmsley, GlaxoSmithKline

GlaxoSmithKline PLC has named Brian McNamara the head of its consumer-health division. The new comes a week after the announcement …
Appointment
abbvie-singapore

AbbVie opens its $300 million manufacturing plant in Singapore

September 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Asia, Singapore

AbbVie’s new Singapore based manufacturing plant is expected to be fully operational by late 2018. The plant is expected to …
News

The October issue of Pharmafocus is now live!

September 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Pharmafocus new issue

The latest edition of Pharmafocus is available online now.
News
janssen_stairs_1

Johnson & Johnson failed to inform FDA over faulty blood testing device in Phase III trial

September 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Johnson & Johnson, Xarelto, phase III, warfarin

The British Medical Journal, after its own investigation, found that Janssen knew early into the Phase III trial, known as …
News
novonordisk

Novo Nordisk to cut 2% of its entire workforce

September 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Denmark, Novo Nordisk, diabetes, insulin, job cuts, job losses

Novo Nordisk, headquartered in Bagsvaerd, Denmark, has taken the decision to lose 1,000 of its workforce from a total global …
News
eylea-product-box-md

NICE approves Bayer’s Eylea for NHS use

September 28, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Eylea, NICE

Bayer has announced that its Eylea (aflibercept) drug has received a final recommendation from NICE for the treatment of visual …
News
china-pharmaceutical-industry

80% of Chinese clinical trials’ data fabricated

September 28, 2016 Manufacturing and Production, Research and Development China, Fabrication, corruption, report

The government review of clinical trial practise involved 1,622 programs of new pharmaceutical drugs waiting upon government approval to begin …
News

Merck elects Isabel De Paoli as CSO

September 27, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CSO, Merck, appointment

German pharma firm Merck has appointed Isabel De Paoli to the position of chief science officer in addition to her …
Appointment
amgen_hq

Amgen’s Kyprolis disappoints in Phase III trial

September 27, 2016 Manufacturing and Production, Research and Development Amgen, Kyprolis, phase III

Amgen was relying on the results of the trial to justify its $10.4 billion purchase of Onyx Pharmaceuticals, acquiring Kyprolis …
News
cancer-389921_960_720

Kite Pharma flying high after promising Car-T trial

September 27, 2016 Manufacturing and Production, Research and Development Cancer, Cart-T, kite pharma

Cart-T cell drugs are made by genetically altering patients’ T-cells to add a component of antibodies that make them better …
News
heather_bresch_2

Price-hiked EpiPen profits 66% higher than Mylan CEO claimed

September 27, 2016 Business Services, Manufacturing and Production, Sales and Marketing Heather Bresch, Mylan, epipen

In the latest development in the Mylan EpiPen scandal, it has been discovered that CEO Heather Bresch lied to US …
News

Sanofi secures $43 million government funding for zika vaccine development

September 27, 2016 Manufacturing and Production, Research and Development BARDA, Sanofi, Zika

The US Department of Health and Human Services approved $43.18 million to fund Sanofi’s development of a zika vaccine, the …
News
jj_2johnson_and_johnson

Johnson & Johnson’s Stelara receives FDA approval

September 27, 2016 Manufacturing and Production, Research and Development Janssen Biotech, Johnson & Johnson, Stelara

The drug is approved for use to treat the skin condition scaly plaque psoriasis and a type of arthritis associated …
News
biogen_austria_238

Biogen closes in on bringing muscular atrophy preventing drug to market

September 26, 2016 Manufacturing and Production, Research and Development Biogen, EMA, FDA, Nusinersen

Biogen has applied for Priority Review, which, if granted, would shorten the review period necessary for nusinersen. They also plan …
News
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026